Attrition of the human leydig cell population with advancing age
β Scribed by Kaler, Lawrence W. ;Neaves, William B.
- Publisher
- John Wiley and Sons
- Year
- 1978
- Tongue
- English
- Weight
- 473 KB
- Volume
- 192
- Category
- Article
- ISSN
- 0003-276X
No coin nor oath required. For personal study only.
β¦ Synopsis
Abstract
Existing evidence suggests that the aging human male experiences a gradual decline in testosterone production, a phenomenon that should be reflected in the Leydig cell population of the testis. It has been proβposed that Leydig cells diminish in number with increasing age, but conflicting claims characterize reports on this topic. We have reinvestigated this possibility by histometric analysis of perfused testes from 25 men ranging from 18 to 87 years of age. Average single Leydig cell volume (2,943 Β± 623 ΞΌm^3^, X S. D.) did not change significantly with increasing age (r = 0.24, P > 0.2), suggesting that surviving cells remain active. Total testis weight (43.5 Β± 13.9 g) also did not change with age (r = 0.04, P > 0.5). However, both total Leydig cell volume and the absolute number of Leydig cells per individual decreased significantly as functions of age (r = β0.71, P < 0.002, and r = β0.61, P < 0.005, respectively). Analysis of the relationship between these two parameters indicates that the total volume of Leydig cell cytoplasm contained within the human testis is determined by the number of cells present. Our results show that a pair of young adult testes endowed with more than 700 million Leydig cells at 20 years of age may be expected to undergo an attrition rate of approximately 80 million cells per subsequent decade of life. Thus, Leydig cell attrition is an important correlate of declining androgen status in aging men.
π SIMILAR VOLUMES
Collagenase-3 (MMP-13) is a matrix metalloproteinase recently identified on the basis of differential expression in normal breast tissues and in breast carcinoma. To date, collagenase-3 expression has been reported only in breast carcinomas and in articular cartilage of arthritic patients; the prese
NM23 is a protein associated with tumor progression, expressed in all tissues and in human tumors. Reduced expression of NM23.H1 is related to high incidence of lymph node and distant metastasis or to poor prognosis of the patient in several human malignant tumors. In this study we analyze NM23 expr
BACKGROUND. This Phase I study was designed to determine the toxicity and efficacy of a carboplatin and irinotecan (CPT-11) regimen with recombinant human granulocyte colony-stimulating factor (rhG-CSF) support for patients with advanced nonsmall cell lung carcinoma. ## METHODS. Treatment consist